Article
Interleukin-28B and fibrosing cholestatic hepatitis in posttransplant hepatitis C: a case-control study and literature review.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society - 1 Dec 2013
Duarte-Rojo Andres, Budhraja Vikram, Veldt Bart J, Goldstein David D, Watt Kymberly D, Heimbach Julie K, McHutchison John G, Tillman Hans L, Poterucha John J, Charlton Michael R
Abstract excerpt
Chronic hepatitis C (CHC)-related cirrhosis is the leading indication for liver transplantation (LT). However, the recurrence of a hepatitis C virus (HCV) infection after transplantation is universal and is associated with worse outcomes. Fibrosing cholestatic hepatitis (FCH) is a particularly severe manifestation of a recurrent HCV infection and frequently results in graft failure and death. The identification...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.